The relationship, in 539 individuals infected with the human immunodeficiency virus (HIV), between two prognostic markers, the CD4 count and beta-2-microglobulin (B2M), and the development of the ...
Impact of prognostic factors on outcome in a phase III study comparing alemtuzumab to chlorambucil as first-line therapy for B-cell chronic lymphocytic leukemia (BCLL) No significant financial ...
Lineage Cell Therapeutics Inc (NYSE:LCTX) has entered into an exclusive option and license agreement with Eterna Therapeutics Inc (NASDAQ:ERNA) for beta 2 microglobulin (B2M)-deficient induced ...
Family history in primary hormone therapy for prostate cancer from a community-based multi-institutional Japan-wide database. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This ...
The panel of 34 human tumours of different histogenetic origins included (snap frozen) tumours of the intestine, stomach, testis, prostate, lung, pancreas, bladder, adrenal gland, cervix, neurologic ...
A blood-borne molecule that increases in abundance as we age blocks regeneration of brain cells and promotes cognitive decline, suggests a new study by researchers at UC San Francisco and Stanford ...
MHC tetramers are typically prepared with most of the commonly used fluorescent labels used for flow cytometry. One major advantage of the technique is that the label is already attached to the ...
Objective To evaluate the threshold value of urinary cadmium (CdU) for renal dysfunction on the basis of relationships unconfounded by protein degradation, diuresis and the renal effects associated ...
Our core provides customized MHC/peptide tetramers for identification of antigen-specific T lymphocytes by flow cytometry. Tetramers and/or their derivatives are provided for research purposes only.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback